Neuberger Berman Group LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 579,328 shares of the company’s stock after selling 80,042 shares during the quarter. Neuberger Berman Group LLC owned 0.18% of HCA Healthcare worth $118,589,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the business. QS Investors LLC lifted its holdings in HCA Healthcare by 61.3% during the 2nd quarter. QS Investors LLC now owns 31,737 shares of the company’s stock worth $6,562,000 after buying an additional 12,058 shares in the last quarter. Tiger Eye Capital LLC lifted its holdings in HCA Healthcare by 10.9% during the 2nd quarter. Tiger Eye Capital LLC now owns 69,343 shares of the company’s stock worth $14,336,000 after buying an additional 6,841 shares in the last quarter. LPL Financial LLC lifted its holdings in HCA Healthcare by 7.1% during the 2nd quarter. LPL Financial LLC now owns 46,397 shares of the company’s stock worth $9,592,000 after buying an additional 3,073 shares in the last quarter. CAPROCK Group Inc. raised its holdings in shares of HCA Healthcare by 1.8% in the 2nd quarter. CAPROCK Group Inc. now owns 2,774 shares of the company’s stock valued at $573,000 after purchasing an additional 48 shares in the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of HCA Healthcare by 11.9% in the 2nd quarter. Franklin Resources Inc. now owns 1,032,330 shares of the company’s stock valued at $213,424,000 after purchasing an additional 109,626 shares in the last quarter. Institutional investors own 68.57% of the company’s stock.
In other news, SVP Jane D. Englebright sold 200 shares of the business’s stock in a transaction that occurred on Thursday, July 29th. The shares were sold at an average price of $249.36, for a total value of $49,872.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jane D. Englebright sold 4,018 shares of the business’s stock in a transaction that occurred on Thursday, August 5th. The shares were sold at an average price of $250.12, for a total transaction of $1,004,982.16. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 59,093 shares of company stock valued at $14,778,068. 1.60% of the stock is currently owned by company insiders.
Shares of NYSE HCA opened at $239.01 on Thursday. The company has a quick ratio of 1.21, a current ratio of 1.45 and a debt-to-equity ratio of 18.06. The stock has a market capitalization of $76.52 billion, a price-to-earnings ratio of 16.39, a price-to-earnings-growth ratio of 1.38 and a beta of 1.65. The firm has a 50-day moving average price of $249.69 and a 200 day moving average price of $224.42. HCA Healthcare, Inc. has a 52 week low of $121.91 and a 52 week high of $263.92.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Monday, July 19th. The company reported $4.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.16 by $1.21. The company had revenue of $14.44 billion during the quarter, compared to analysts’ expectations of $13.61 billion. HCA Healthcare had a net margin of 8.87% and a return on equity of 234.29%. The firm’s quarterly revenue was up 30.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.23 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 16.78 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 30th. Shareholders of record on Thursday, September 16th were given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend was Wednesday, September 15th. HCA Healthcare’s payout ratio is currently 16.54%.
About HCA Healthcare
HCA Healthcare, Inc is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.